The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration

The regeneration of bone defects in osteoporotic patients presents a big challenge. Icariin (Ica), which is the main active component of traditional Chinese medicine - herba epimedii, has been widely loaded to scaffolds for the treatment of bone fracture and osteoporosis. To increase drug loading ca...

Full description

Bibliographic Details
Main Authors: Zhaocong Luo, Xuening Chen, Minjun Liu, Yuyi Wang, Dongxiao Li, Xiangfeng Li, Yumei Xiao, Yan Wang, Xingdong Zhang
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Materials & Design
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0264127521000216
_version_ 1819160565678866432
author Zhaocong Luo
Xuening Chen
Minjun Liu
Yuyi Wang
Dongxiao Li
Xiangfeng Li
Yumei Xiao
Yan Wang
Xingdong Zhang
author_facet Zhaocong Luo
Xuening Chen
Minjun Liu
Yuyi Wang
Dongxiao Li
Xiangfeng Li
Yumei Xiao
Yan Wang
Xingdong Zhang
author_sort Zhaocong Luo
collection DOAJ
description The regeneration of bone defects in osteoporotic patients presents a big challenge. Icariin (Ica), which is the main active component of traditional Chinese medicine - herba epimedii, has been widely loaded to scaffolds for the treatment of bone fracture and osteoporosis. To increase drug loading capacity, and meanwhile achieve a stable and safe drug delivery, in present study, a novel icariin derivative - thiolated icariin (Ica-SH) molecule with good cytocompatibility and bioactivity was incorporated into biphasic calcium phosphate (BCP) ceramic scaffold through Ica-SH intermolecular disulfide bonds (abbr., Ica-SH/BCP) to form film coating. Compared with Ica-loaded BCP scaffolds via physical adsorption (abbr., Ica/BCP), the formation of Ica-SH intermolecular disulfide bonds in Ica-SH/BCP scaffolds led to a decreased real-time drug release concentration, and a reduced drug release rate. The released drug from Ica-SH/BCP scaffolds could promote the proliferation, migration, and osteoblastic differentiation of ovariectomized rat bone mesenchymal stem cells (OVX-rBMSCs), and up-regulate the angiogenic gene expression in human umbilical vein endothelial cells (HUVECs) in vitro. The OVX-rat femoral condyle defect model also demonstrated that Ica-SH/BCP scaffolds promoted a superior bone regeneration in osteoporotic animals than BCP ones. These findings suggest that Ica-SH is a promising drug, which can be facilely incorporated into a variety of scaffolds for repairing bone defects of patients, in particular the ones with osteoporosis.
first_indexed 2024-12-22T16:58:28Z
format Article
id doaj.art-1afabd0db0e343328470ab279c79c998
institution Directory Open Access Journal
issn 0264-1275
language English
last_indexed 2024-12-22T16:58:28Z
publishDate 2021-02-01
publisher Elsevier
record_format Article
series Materials & Design
spelling doaj.art-1afabd0db0e343328470ab279c79c9982022-12-21T18:19:23ZengElsevierMaterials & Design0264-12752021-02-01200109468The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regenerationZhaocong Luo0Xuening Chen1Minjun Liu2Yuyi Wang3Dongxiao Li4Xiangfeng Li5Yumei Xiao6Yan Wang7Xingdong Zhang8National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, ChinaNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, ChinaNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, ChinaNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, ChinaSichuan Academy of Chinese Medicine Science, Chengdu, Sichuan, ChinaNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, ChinaNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, China; Corresponding authors.Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China; Corresponding authors.National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 61004, Sichuan, ChinaThe regeneration of bone defects in osteoporotic patients presents a big challenge. Icariin (Ica), which is the main active component of traditional Chinese medicine - herba epimedii, has been widely loaded to scaffolds for the treatment of bone fracture and osteoporosis. To increase drug loading capacity, and meanwhile achieve a stable and safe drug delivery, in present study, a novel icariin derivative - thiolated icariin (Ica-SH) molecule with good cytocompatibility and bioactivity was incorporated into biphasic calcium phosphate (BCP) ceramic scaffold through Ica-SH intermolecular disulfide bonds (abbr., Ica-SH/BCP) to form film coating. Compared with Ica-loaded BCP scaffolds via physical adsorption (abbr., Ica/BCP), the formation of Ica-SH intermolecular disulfide bonds in Ica-SH/BCP scaffolds led to a decreased real-time drug release concentration, and a reduced drug release rate. The released drug from Ica-SH/BCP scaffolds could promote the proliferation, migration, and osteoblastic differentiation of ovariectomized rat bone mesenchymal stem cells (OVX-rBMSCs), and up-regulate the angiogenic gene expression in human umbilical vein endothelial cells (HUVECs) in vitro. The OVX-rat femoral condyle defect model also demonstrated that Ica-SH/BCP scaffolds promoted a superior bone regeneration in osteoporotic animals than BCP ones. These findings suggest that Ica-SH is a promising drug, which can be facilely incorporated into a variety of scaffolds for repairing bone defects of patients, in particular the ones with osteoporosis.http://www.sciencedirect.com/science/article/pii/S0264127521000216Thiolated icariinControlled releaseHigh loading capacityOsteoporotic bone regenerationBCP ceramic
spellingShingle Zhaocong Luo
Xuening Chen
Minjun Liu
Yuyi Wang
Dongxiao Li
Xiangfeng Li
Yumei Xiao
Yan Wang
Xingdong Zhang
The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
Materials & Design
Thiolated icariin
Controlled release
High loading capacity
Osteoporotic bone regeneration
BCP ceramic
title The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
title_full The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
title_fullStr The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
title_full_unstemmed The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
title_short The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
title_sort controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration
topic Thiolated icariin
Controlled release
High loading capacity
Osteoporotic bone regeneration
BCP ceramic
url http://www.sciencedirect.com/science/article/pii/S0264127521000216
work_keys_str_mv AT zhaocongluo thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT xueningchen thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT minjunliu thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT yuyiwang thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT dongxiaoli thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT xiangfengli thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT yumeixiao thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT yanwang thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT xingdongzhang thecontrolledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT zhaocongluo controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT xueningchen controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT minjunliu controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT yuyiwang controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT dongxiaoli controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT xiangfengli controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT yumeixiao controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT yanwang controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration
AT xingdongzhang controlledreleaseofanovelthiolatedicariinforenhancedosteoporoticboneregeneration